Study design & results
Available in the Gosset platform where reported.
Trial intelligence / Profile preview
Phase II study of topical QY101 ointment in plaque psoriasis
CTR20230730Phase 2Active
- Sponsor
- Origin Biosciences
- Start
- May 2023
- Modality
- Small Molecules
- Countries
- 1
01
Overview
A Phase 2 trial of QY101 in plaque psoriasis, sponsored by Origin Biosciences. Started May 2023; status: active.
02
Drugs
QY101
03
Conditions
plaque psoriasis
Beyond the preview
Go deeper on CTR20230730.
Study design, results and competitive context are available in the Gosset platform where reported.
Competitive context
Available in the Gosset platform where reported.
Bring the full picture into focus.
See how Gosset can support your research on CTR20230730.